Cargando…
Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson’s Disease
Mounting evidence suggests that ferroptosis is not just a consequence but also a fundamental contributor to the development and progression of Parkinson’s disease (PD). Ferroptosis is characterized as iron-dependent regulated cell death caused by excessive lipid peroxidation, leading to plasma membr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615560/ https://www.ncbi.nlm.nih.gov/pubmed/34829907 http://dx.doi.org/10.3390/biomedicines9111679 |
_version_ | 1784604133943148544 |
---|---|
author | Ko, Chih-Jan Gao, Shih-Ling Lin, Tsu-Kung Chu, Pei-Yi Lin, Hung-Yu |
author_facet | Ko, Chih-Jan Gao, Shih-Ling Lin, Tsu-Kung Chu, Pei-Yi Lin, Hung-Yu |
author_sort | Ko, Chih-Jan |
collection | PubMed |
description | Mounting evidence suggests that ferroptosis is not just a consequence but also a fundamental contributor to the development and progression of Parkinson’s disease (PD). Ferroptosis is characterized as iron-dependent regulated cell death caused by excessive lipid peroxidation, leading to plasma membrane rupture, release of damage-associated molecular patterns, and neuroinflammation. Due to the crucial role of intracellular iron in mediating the production of reactive oxygen species and the formation of lipid peroxides, ferroptosis is intimately controlled by regulators involved in many aspects of iron metabolism, including iron uptake, storage and export, and by pathways constituting the antioxidant systems. Translational and transcriptional regulation of iron homeostasis and redox status provide an integrated network to determine the sensitivity of ferroptosis. We herein review recent advances related to ferroptosis, ranging from fundamental mechanistic discoveries and cutting-edge preclinical animal studies, to clinical trials in PD and the regulation of neuroinflammation via ferroptosis pathways. Elucidating the roles of ferroptosis in the survival of dopaminergic neurons and microglial activity can enhance our understanding of the pathogenesis of PD and provide opportunities for the development of novel prevention and treatment strategies. |
format | Online Article Text |
id | pubmed-8615560 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86155602021-11-26 Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson’s Disease Ko, Chih-Jan Gao, Shih-Ling Lin, Tsu-Kung Chu, Pei-Yi Lin, Hung-Yu Biomedicines Review Mounting evidence suggests that ferroptosis is not just a consequence but also a fundamental contributor to the development and progression of Parkinson’s disease (PD). Ferroptosis is characterized as iron-dependent regulated cell death caused by excessive lipid peroxidation, leading to plasma membrane rupture, release of damage-associated molecular patterns, and neuroinflammation. Due to the crucial role of intracellular iron in mediating the production of reactive oxygen species and the formation of lipid peroxides, ferroptosis is intimately controlled by regulators involved in many aspects of iron metabolism, including iron uptake, storage and export, and by pathways constituting the antioxidant systems. Translational and transcriptional regulation of iron homeostasis and redox status provide an integrated network to determine the sensitivity of ferroptosis. We herein review recent advances related to ferroptosis, ranging from fundamental mechanistic discoveries and cutting-edge preclinical animal studies, to clinical trials in PD and the regulation of neuroinflammation via ferroptosis pathways. Elucidating the roles of ferroptosis in the survival of dopaminergic neurons and microglial activity can enhance our understanding of the pathogenesis of PD and provide opportunities for the development of novel prevention and treatment strategies. MDPI 2021-11-12 /pmc/articles/PMC8615560/ /pubmed/34829907 http://dx.doi.org/10.3390/biomedicines9111679 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Ko, Chih-Jan Gao, Shih-Ling Lin, Tsu-Kung Chu, Pei-Yi Lin, Hung-Yu Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson’s Disease |
title | Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson’s Disease |
title_full | Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson’s Disease |
title_fullStr | Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson’s Disease |
title_full_unstemmed | Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson’s Disease |
title_short | Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson’s Disease |
title_sort | ferroptosis as a major factor and therapeutic target for neuroinflammation in parkinson’s disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615560/ https://www.ncbi.nlm.nih.gov/pubmed/34829907 http://dx.doi.org/10.3390/biomedicines9111679 |
work_keys_str_mv | AT kochihjan ferroptosisasamajorfactorandtherapeutictargetforneuroinflammationinparkinsonsdisease AT gaoshihling ferroptosisasamajorfactorandtherapeutictargetforneuroinflammationinparkinsonsdisease AT lintsukung ferroptosisasamajorfactorandtherapeutictargetforneuroinflammationinparkinsonsdisease AT chupeiyi ferroptosisasamajorfactorandtherapeutictargetforneuroinflammationinparkinsonsdisease AT linhungyu ferroptosisasamajorfactorandtherapeutictargetforneuroinflammationinparkinsonsdisease |